Clinical Trial Update: Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri

View source ↗

Summary

The completed clinical trial update assesses the safety and efficacy of natalizumab (Tysabri) in pediatric patients with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED